US EditionPublished • loading... • Updated
The EVERY Co and Onego Bio eyed $400m merger before IP talks went south, court docs reveal
Summary by AgFunderNews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The EVERY Co and Onego Bio eyed $400m merger before IP talks went south, court docs reveal
Alt-egg startups The EVERY Company and Onego Bio had been discussing a merger to create a new company with a valuation of $400m before talks fell apart and Onego sued its rival, court documents reveal. Details of the talks were shared in an October 28 legal filing by The EVERY Co, which urged a court in Wisconsin to toss a lawsuit* from Onego Bio seeking to invalidate one of EVERY’s patents. The IP at issue covers the production of ovalbumin, th…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
